Search results for "Cirrhosis"


 
Results 61 - 70 of about 123 for "Cirrhosis".
Sort by: Relevance | Newest | Oldest

Spotlight on HCV guidance

Recommendations from the U.S. Preventive Services Task Force, the Kidney Disease: Improving Global Outcomes (KDIGO) work group, and the Choosing Wisely campaign all focused on hepatitis C virus (HCV) infection.
https://gastroenterology.acponline.org/archives/2019/09/27/5.htm
27 Sep 2019

ACIP updates hepatitis A vaccination recommendations

The Advisory Committee on Immunization Practices (ACIP) changed its recommendations regarding vaccination of patients with chronic liver disease, pregnant women, and those treated with blood products for clotting disorders, among other revisions.
https://gastroenterology.acponline.org/archives/2020/07/24/1.htm
24 Jul 2020

Recent conference coverage featured gastroenterology and hepatology topics

Conference coverage in the December ACP Hospitalist addressed acute-on-chronic liver failure and inpatient constipation.
https://gastroenterology.acponline.org/archives/2018/12/28/8.htm
28 Dec 2018

Nearly all patients in study achieved sustained virologic response after 12 weeks of new HCV treatment

The drug combination appeared effective in adults with HCV genotypes 1, 2, 4, 5, or 6 infection and compensated cirrhosis in the industry-funded trial.
https://gastroenterology.acponline.org/archives/2017/08/25/3.htm
25 Aug 2017

NAFLD practice guidance issued for screening, treatment

The guidance, from the American Association for the Study of Liver Diseases, notes that routine screening for nonalcoholic fatty liver disease (NAFLD) in a primary care setting or obesity clinics is not typically recommended due to uncertainties in long-term benefits and cost-effectiveness.
https://gastroenterology.acponline.org/archives/2017/07/28/2.htm
28 Jul 2017

Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response

A commentary in ACP Journal Club noted that while screening and treating all patients with chronic hepatitis C virus (HCV) would be cost-effective and probably cost-saving, some payers are still resistant.
https://gastroenterology.acponline.org/archives/2017/07/28/11.htm
28 Jul 2017

Prevalence of liver fibrosis in diabetes suggests need for earlier intervention, study finds

The prevalence of any suspected liver fibrosis in patients with diabetes was 21% in a recent study, leading the authors to call for more aggressive screening in patients with obesity and diabetes.
https://gastroenterology.acponline.org/archives/2021/01/22/3.htm
22 Jan 2021

MKSAP Quiz: Confusion and a history of cirrhosis

This month's quiz asks readers to determine the most appropriate next step in evaluation in the ED for a 56-year-old patient with symptoms of progressive confusion and a history of cirrhosis due to alcohol use, as well as depression and anxiety.
https://gastroenterology.acponline.org/archives/2023/03/24/4.htm
24 Mar 2023

HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists

Reversing insurance restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://gastroenterology.acponline.org/archives/2017/08/25/6.htm
25 Aug 2017

Model that blends machine learning, traditional risk score may improve cirrhosis prediction

Using clinical variables identified from simple machine learning in a cirrhosis mortality model produced a new score that was more transparent than a commonly used version of the Model for End-Stage Liver Disease, a study found.
https://gastroenterology.acponline.org/archives/2020/11/20/3.htm
20 Nov 2020

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next